Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0WMI
|
||||
| Drug Name |
N-(5-cyclohexyl-2-methoxyphenyl)-4-methyl-3-(3-(2-(methylamino)pyrimidin-4-yl)pyridin-2-yloxy)benzamide
|
||||
| Synonyms |
CHEMBL220550
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C31H33N5O3
|
||||
| Canonical SMILES |
CNc1nccc(n1)c2cccnc2Oc3cc(ccc3C)C(=O)Nc4cc(ccc4OC)C5CCCCC5
|
||||
| InChI |
InChI=1S/C31H33N5O3/c1-20-11-12-23(29(37)35-26-18-22(13-14-27(26)38-3)21-8-5-4-6-9-21)19-28(20)39-30-24(10-7-16-33-30)25-15-17-34-31(32-2)36-25/h7,10-19,21H,4-6,8-9H2,1-3H3,(H,35,37)(H,32,34,36)
|
||||
| InChIKey |
KGUBPBXMEHAZKB-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.